Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,969,231
-
Total 13F shares
-
358,561
-
Share change
-
+15,448
-
Total reported value
-
$1,881,000
-
Price per share
-
$5.17
-
Number of holders
-
11
-
Value change
-
+$104,639
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2020
As of 30 Jun 2020,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
358,561 shares.
The largest 10 holders included
Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, Tower Research Capital LLC (TRC), FNY Investment Advisers, LLC, Covington Capital Management, TRUE Private Wealth Advisors, UBS Group AG, and Private Advisor Group, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.